Association for Research in Vision and Ophthalmology (ARVO) 2021

Loading Events

Innovation and advanced technologies have fostered significant discoveries in eye and vision research in the last decade rivaling those in any discipline. The theme of the 2021 ARVO Annual Meeting is the next revolution of clinically translating these discoveries to restore and preserve vision.

Mogrify® is applying its proprietary suite of platform, MOGRIFY® (Rackham et al., Nature Genetics, 2016) and EpiMOGRIFY (Kamaraj et al., Cell Systems 2020), to engineer a renewable and scalable source of cell types that exhibit efficacy and safety profiles necessary to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies for indications of high unmet clinical need in hematological, immunological, ophthalmological and other disease areas.

Mogrify is looking to partner with disruptive innovators in the fields of regenerative medicine, ex vivo cell therapy and in vivo reprogramming therapy to develop treatments for indications of high unmet clinical.

Meet with us or learn more about our science.

Go to Top